Trials / Completed
CompletedNCT05689333
A Study to Evaluate the Safety and Performance of the Vista Probe for Vitrectomy Surgery
A Prospective, Single-arm, Non-comparative, Open-label, Monocular, Post Approval Study to Assess Safety and Device Performance of the Vista Vitrectomy Probe During Vitrectomy Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- VISTA Ophthalmics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, single-arm, non-comparative, open-label, monocular, post approval study to assess safety and device performance of the Vista Vitrectomy Probe during vitrectomy surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Vista Vitrectomy Probe | Vitrectomy will be performed through 27 GA Vista Ophthalmics vitrector |
Timeline
- Start date
- 2022-12-09
- Primary completion
- 2024-05-07
- Completion
- 2024-05-07
- First posted
- 2023-01-19
- Last updated
- 2025-04-01
Locations
4 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05689333. Inclusion in this directory is not an endorsement.